Company intelligence / Profile preview
Wulf Rabe's Biologische Mittel
- Ownership
- Private
- Development stage
- Other
Overview
Wulf Rabe's Biologische Mittel is a German pharmaceutical company specializing in natural remedies, homeopathy, and mistletoe-based therapies. Founded in 1920 by naturopath Wulf Rabe, the company is best known for its flagship product Rabjuvèn, a mistletoe preparation first registered in 1939 as a cancer treatment. The company's portfolio also includes the Bio-Serie, Rabe-Komplexe, and preparations for Koch's molecular therapy. After being managed by adjupharm GmbH for over a decade, the brand and its product lines were acquired by Sanorell Pharma GmbH in mid-2023, where they continue to be manufactured and distributed.
- Therapeutic areas
- OncologyImmunology
- Modalities
- Plant extractBotanical extractHerbal medicineHomeopathic remedy
- Industry
- Pharma
Drug pipeline
1 assetBeyond the preview
Go deeper on Wulf Rabe's Biologische Mittel.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Wulf Rabe's Biologische Mittel.